| Gene Symbol | AD |
| Blood-based panel (6 markers) | Aβ42/Aβ40, p-Tau217, p-Tau231, NfL, GFAP, sTREM2 |
| CSF panel (8 markers) | All above plus neurogranin and SNAP-25 |
| Optimal approach | Blood for screening, CSF for confirmation and staging |
| Associated Diseases | ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, CORTICOBASAL DEGENERATION, CREUTZFELDT-JAKOB, DEMENTIA, FRONTOTEMPORAL DEMENTIA |
| Known Drugs/Compounds | HTL9936, resveratrol |
| Interactions | AB, ABCA1, ACHE, ADAM10, ADAM17, AIF1 |
| SciDEX Hypotheses | Stratified falsifiers should govern AD Master Plan Stratified falsifiers should govern AD Master Plan Stratified falsifiers should govern AD Master Plan (+2 more) |
| KG Connections | 1498 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
No AI portrait yet
No comments yet. Be the first to comment!